PRCSG News

Abstracts  / Posters / Presentations

 

CARRA 2019 Annual Scientific Meeting, April 10 - 14 

  • Long-Term Safety of Subcutaneous Tocilizumab Administration in Systemic and Polyarticular Juvenile Idiopathic Arthritis (612210)

 

  • Disability and Health-Related Quality of Like Outcomes in Patients With Systemic or Polyarticular Juvenile Idiopathic Arthritis Treated With Tocilizumab in Randomized Controlled Phase 3 Trials (614044)

 

 21 PANLAR 2019, April 27 - 30

  • Efficacy and safety of intravenous golimumab in patients with juvenile idiopathic arthritis: Results from a Phase 3 open-label study (#323)

*******************************************************************************************

September 2018 - FDA approves subcutaneous formulation of ACTEMRA for systemic JIA 

 

Revised Common Rule: educational videos created by OHRP

 

May 2018 - FDA approves subcutaneous formulation of Actemra for use is Polyarticular Juvenile Idiopathic Arthritis